Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Ironwood Pharmaceuticals (IRWD) Long-Term Debt Issuances (2017 - 2023)

Ironwood Pharmaceuticals' Long-Term Debt Issuances history spans 4 years, with the latest figure at $400.0 million for Q2 2023.

On a quarterly basis, Long-Term Debt Issuances changed N/A to $400.0 million in Q2 2023 year-over-year; TTM through Dec 2024 was $400.0 million, a 0.0% change, with the full-year FY2024 number at $150.0 million, down 62.5% from a year prior.
Long-Term Debt Issuances hit $400.0 million in Q2 2023 for Ironwood Pharmaceuticals, up from $146.2 million in the prior quarter.
Over the last five years, Long-Term Debt Issuances for IRWD hit a ceiling of $400.0 million in Q2 2023 and a floor of $400.0 million in Q2 2023.